Autologous stem cell transplantation for adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. A study by the Acute Leukemia Working Party of the EBMT

Autologous hematopoietic stem cell transplantation is relatively safe option of late treatment intensification in adults with Ph- ALL. It may be a valuable option especially in patients with TCP-ALL, however it should be proved in prospective clinical trials.

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2025-04-28
DOI
https://doi.org/10.1186/s12885-025-14126-8
Primary Topic
Acute Lymphoblastic Leukemia research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Autologous stem cell transplantation for adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. A study by the Acute Leukemia Working Party of the EBMT

Myriam Labopin, Е. Н. Паровичникова, Jiří Pavlů, Mohamad Mohty et al.
BMC Cancer
Acute Lymphoblastic Leukemia research
article

Autologous stem cell transplantation for adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. A study by the Acute Leukemia Working Party of the EBMT

Myriam Labopin, Е. Н. Паровичникова, Jiří Pavlů, Mohamad Mohty, Anna Kopińska, Jurjen Versluis, Fabio Ciceri, Francesco Lanza, Ryszard Swoboda, Alessandro Rambaldi, David Nachbaur, Norbert Claude Gorin, František Folber, Johan A. Maertens, Luděk Raida, Saveria Capria, Mustafa Öztürk, Denis Caillot, Marie Thérèse Rubio, Mahmoud Aljurf, Arnon Nagler, Sebastian Giebel
article en

Abstract

Autologous hematopoietic stem cell transplantation is relatively safe option of late treatment intensification in adults with Ph- ALL. It may be a valuable option especially in patients with TCP-ALL, however it should be proved in prospective clinical trials.

BMC CancerVol. 25(1)
Military Medical Academy (RS), Innsbruck Medical University (AT), Medical University of Silesia (PL), Masaryk University (CZ), Sheba Medical Center (IL), Turkish Armed Forces (TR), Universitair Ziekenhuis Leuven (BE), King Faisal Specialist Hospital & Research Centre (SA), Hammersmith Hospital (GB), Erasmus MC (NL), Sorbonne Université (FR), Centre Hospitalier Régional et Universitaire de Nancy (FR), University Hospital Brno (CZ), Hôpital Saint-Antoine (FR), Hôpital d'Enfants (FR), Ospedale Papa Giovanni XXIII (IT), University Hospital Olomouc (CZ), Azienda Unità Sanitaria Locale Della Romagna (IT), CHU Dijon Bourgogne (FR), National Research Center for Hematology Russian Academy of Medical Sciences (RU), IRCCS Ospedale San Raffaele (IT), The Maria Sklodowska-Curie National Research Institute of Oncology (PL), European Society for Blood and Marrow Transplantation (FR), Palacký University Olomouc (CZ), Sapienza University of Rome (IT), University of Bologna (IT)
Openalex Percentile: Top 88%
Acute Lymphoblastic Leukemia research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.